ITC Opens Investigation Into Melanoma Predictive Tests
August 28, 2026
August 28, 2026
WASHINGTON, Aug. 28 (TNSFR) -- The International Trade Commission has instituted an investigation into melanoma predictive and prognostic tests and related components following a complaint by Castle Biosciences Inc. of Friendswood, Texas.
The complaint, filed July 10, 2026, alleges violations of Section 337 of the Tariff Act through unfair competition involving false and misleading advertising in connection with imported or sold melanoma tests. Castle requested a limited exclusion o . . .
The complaint, filed July 10, 2026, alleges violations of Section 337 of the Tariff Act through unfair competition involving false and misleading advertising in connection with imported or sold melanoma tests. Castle requested a limited exclusion o . . .